Pepcid and Azacitidine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pepcid (famotidine) and Azacitidine (azacitidine). Common drug interactions include streptococcal bacteraemia among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Pepcid and Azacitidine. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.

What is Pepcid?

Pepcid has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 55,774 Pepcid users. Check the latest studies of Pepcid.

What is Azacitidine?

Azacitidine has active ingredients of azacitidine. eHealthMe is studying from 17,184 Azacitidine users. Check the latest studies of Azacitidine.



On Jul, 27, 2026

49 people who take Pepcid and Azacitidine together, and have interactions are studied.

Pepcid and Azacitidine drug interactions.

What are the common drug interactions of Pepcid and Azacitidine, by gender? *:

female:

  1. Streptococcal bacteraemia (a bacterial infection of blood)
  2. Intestinal obstruction
  3. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  4. Death
  5. Febrile neutropenia (fever with reduced white blood cells)
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Anaemia (lack of blood)
  8. Fatigue (feeling of tiredness)
  9. Myocardial oedema (heart muscle swelling)
  10. Haemoglobin decreased

male:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Muscular weakness (muscle weakness)
  3. Blood alkaline phosphatase increased
  4. Blood bilirubin increased
  5. Septic shock (shock due to blood infection)
  6. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  7. Blood pressure systolic increased
  8. Death
  9. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  10. Haemoglobin decreased

What are the common drug interactions of Pepcid and Azacitidine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Muscular weakness (muscle weakness)
  2. Myelitis (infection or the inflammation of white matter or gray matter of spinal cord which is a part of central nervous system)
  3. Osteosarcoma recurrent (reoccurrence of a cancerous (malignant) bone tumour)
  4. Urinary incontinence (inability to control the flow of urine and involuntary urination)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Pruritus (severe itching of the skin)
  2. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  3. Device related infection
  4. Failure to thrive (inadequate weight gain and physical growth in children)
  5. Fatigue (feeling of tiredness)
  6. Gait disturbance
  7. Hypophagia (reduced food intake)
  8. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  9. Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

60+:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Streptococcal bacteraemia (a bacterial infection of blood)
  3. Aspartate aminotransferase increased
  4. Blood alkaline phosphatase increased
  5. Blood bilirubin increased
  6. Blood pressure increased
  7. Fatigue (feeling of tiredness)
  8. Haemoglobin decreased
  9. Heart rate increased
  10. Septic shock (shock due to blood infection)

What are the existing conditions these people have? *

  1. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 28 people, 57.14%
  2. Nausea (feeling of having an urge to vomit): 19 people, 38.78%
  3. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 14 people, 28.57%
  4. Constipation: 14 people, 28.57%
  5. Diarrhea: 11 people, 22.45%
  6. Stress And Anxiety: 10 people, 20.41%
  7. Pain: 8 people, 16.33%
  8. Insomnia (sleeplessness): 7 people, 14.29%
  9. High Blood Pressure: 7 people, 14.29%
  10. Depression: 7 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Pepcid and Azacitidine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pepcid and Azacitidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pepcid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Azacitidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pepcid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Azacitidine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on famotidine and azacitidine (the active ingredients of Pepcid and Azacitidine, respectively), and Pepcid and Azacitidine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: